RAPP Stock-Based Compensation

Rapport Therapeutics Inc · Stock-Based Compensation

RAPP logo

RAPP Stock-Based Compensation

Latest reported$7.20M
RAPP Quarterly Stock-Based Comp ($723.00K → $7.20M)
High-resolution chart · PNG

RAPP stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Rapport Therapeutics Inc Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
7,202,000
6,963,000
5,691,000
4,735,000
4,389,000
4,040,000
3,208,000
3,182,000
2,354,000
1,491,000
998,000
859,000
945,000
723,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.